Work

Association between the 4-week platelet count rise rate after diagnosis and the risk of chronicity at 12 months in children with immune thrombocytopenia

Year: 2026
Type: article
Study design: Observational Study
Abstract: Background Chronic immune thrombocytopenia (ITP) in children can cause recurrent bleeding, prolonged follow-up, and increased treatment exposure. This study assessed whether the 4-week platelet count rise rate after diagnosis was independently associated with chronicity at 12 months and explored its threshold performance for early risk stratification. Methods This single-center retrospective study included 335 children aged <18 years with newly diagnosed primary ITP from January 2018 to December 2023. The platelet count rise rate was calculated as the average weekly increase from diagnosis to the 4-week assessment (×10 9 /L/week). Chronicity was defined as platelet count <100 × 10 9 /L at 12 months, ITP-related treatment at 12 months, or ITP-related treatment within the preceding 4 weeks. Independent associations were examined using multivariable logistic regression and quartile trend analysis. Threshold performance was evaluated using receiver operating characteristic (ROC) analysis, bootstrap internal validation, decision curve analysis (DCA), treatment-stratified analyses, and sensitivity analyses. Results Chronic ITP developed in 86 children (25.7%). Chronicity decreased across platelet count rise-rate quartiles from 63.1% in Q1 to 3.6% in Q4 ( P for trend < 0.001 ). After adjustment for demographic, clinical, laboratory, bleeding-related, and treatment-related factors, each 10 × 10 9 /L/week increase in platelet count rise rate was associated with lower odds of chronicity (adjusted odds ratio, 0.37; 95% confidence interval, 0.27–0.50; P < 0.001 ). The area under the ROC curve for a lower rise rate was 0.846 (95% confidence interval, 0.794–0.891), and the bootstrap optimism-corrected value was 0.833 (95% confidence interval, 0.779–0.883). The exploratory cutoff of ≤20.5 × 10 9 /L/week yielded 76.7% sensitivity, 77.5% specificity, 54.1% positive predictive value, and 90.6% negative predictive value; bootstrap cutoffs ranged from 18.6 to 22.4 × 10 9 /L/week. DCA showed net benefit across threshold probabilities of 10%–45%. Conclusions A lower 4-week platelet count rise rate was independently associated with 12-month chronicity in pediatric primary ITP. A rate above the exploratory cutoff may identify children at low chronicity risk and support follow-up stratification. External validation is required before clinical adoption, and the cutoff should complement comprehensive clinical assessment rather than guide treatment escalation alone.
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7235934284
FWCI:
Cites: 36
Cited by:
Related to: 10
Parts: 1